Singapore: The medical device regulators of Australia, Brazil, Canada and the US have all signed on to a statement of co...
Singapore: Research on treatment of Alzheimer's disease received a fillip with Australian scientists working on it recei...
Singapore: India generated the nearly one-fourth of the global revenue of the lifescience market in APAC. Highlig...
Singapore: Australia was the third largest contributor to the lifescience market in the region Highlights • An ...
Singapore: The University of Queensland-based biotechnology company Protagonist Therapeutics has secured $14 million in ...
Singapore: AdiStem, a provider of photo activation technology and medical solutions, highlighted that platelet rich pla...
Singapore: AusBiotech, the bioscience industry organization of Australia, has told the government that patent length in ...
Valentine's Day, which is marked as a day to commemorate the death anniversary of Saint Valentine, saw the birth of a ve...
Singapore: New Zealand-based biopharmaceutical company Innate Immunotherapeutics is migrating to Australia in a move to ...
Singapore: Dr Anna Lavelle, CEO, AusBiotech, has been elected to Fellowship of the Australian Academy of Technological S...
Singapore: Australia's healthcare company focused on investing in and developing next generation technologies, Admedus, ...
With 11 percent share and $11.65 billion is revenue, Australia grew marginally. It has been a bad year or Australia's...
Singapore: Australia-based Mayne Pharma has struck a deal to acquire Doryx acne-treatment brand and assets in the US for...
Singapore: Australia's regenerative medicine company, Orthocell, has recieved Chinese patent for its Collagen Scaffold f...
Singapore: Serum Institute of India (SII) has applied for permits to export flu vaccines produced using Australia's BioD...
Singapore: Australia-based QRxPharma has resubmitted its Moxduo new drug application (NDA) after the US Food and Drug Ad...
The press release indicated that Immutep is a French company and is a 100 percent subsidiary of Prima BioMed. Immutep de...
Singapore: Melbourne-based Phosphagenics has resolved all crystallisation issues associated with its opioid patch devel...
